119 related articles for article (PubMed ID: 6807843)
1. Serial measurement of circulating immune complexes in healthy subjects.
Puskás E; Füst G; Angyal I; Nguyen-Chi-Phi ; Gergely J
Immunol Lett; 1982 Apr; 4(4):223-7. PubMed ID: 6807843
[TBL] [Abstract][Full Text] [Related]
2. Polyethylene glycol enhances the binding of C1q to circulating immune complexes.
Hack CE; Eerenberg-Belmer AJ; Hannema AJ; Out TA; Aalberse RC
J Immunol Methods; 1981; 44(2):211-21. PubMed ID: 6792284
[TBL] [Abstract][Full Text] [Related]
3. Correlation between circulating antigens detected by the radioimmunoprecipitation-polyethylene glycol assay (RIPEGA) and C1q-binding immune complexes in human schistosomiasis mansoni.
Santoro F; Prata A; Silva AE; Capron A
Am J Trop Med Hyg; 1981 Sep; 30(5):1020-5. PubMed ID: 6974508
[TBL] [Abstract][Full Text] [Related]
4. [Correlations between complement degradation products and circulating immune complexes in human glomerulonephritis].
Coppo R; De Marchi M; Alloatti S; Segoloni G; Giacchino F; Quarello F; Roccatello D; Bulzomi MR; Piccoli G
Minerva Nefrol; 1979; 26(3):243-50. PubMed ID: 318057
[No Abstract] [Full Text] [Related]
5. Circulating immune complexes in the sera and ascites of hepatocellular carcinoma or chronic hepatitis patients.
Chen YM; Hu CP; Wong FH; Chen PH; Tsai YT; Lee SD; Liu JD; Chang CM
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Feb; 19(1):34-45. PubMed ID: 3028719
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the soluble immune complexes that are detected by three different techniques.
van der Giessen M; The TH
Clin Immunol Immunopathol; 1986 Feb; 38(2):244-55. PubMed ID: 3484441
[TBL] [Abstract][Full Text] [Related]
7. Ability to activate complement is not required for the detection of immune complexes by the fluid-phase C1q binding assay.
Fiocco GP; Davis JS; Burge JJ
Arthritis Rheum; 1985 Feb; 28(2):222-5. PubMed ID: 3871617
[No Abstract] [Full Text] [Related]
8. Circulating immune complex-like materials which bind to heat inactivated C1q interfere with the C1q solid phase assay for immune complexes.
Fukuda K; Seino J; Kinoshita Y; Sudo K; Horigome I; Saito T; Furuyama T; Yoshinaga K
Tohoku J Exp Med; 1985 Aug; 146(4):449-56. PubMed ID: 3907015
[TBL] [Abstract][Full Text] [Related]
9. Measurement of circulating immune complexes in human sera by enzyme immunoassay.
Cheung K; O'Kane D; Robinson MF
Aust J Exp Biol Med Sci; 1982 Dec; 60(6):593-605. PubMed ID: 6820632
[TBL] [Abstract][Full Text] [Related]
10. [Specificity, sensitivity and reproducibility of 2 methods of determining serum immunocomplexes (solid-phase C1q and polyethylene glycol precipitation)].
Coppo R; De Marchi M; Basolo B; Martina G; Rollino C; Boero R; Giraudo G; Rossano C; Quarello F; Piccoli G
Arch Sci Med (Torino); 1982; 139(4):381-92. PubMed ID: 6984818
[TBL] [Abstract][Full Text] [Related]
11. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
12. Fibronectin binding to C1q associated with antigen-antibody complexes in EDTA-treated plasma.
Sorvillo J; Gigli I; Pearlstein E
Scand J Immunol; 1986 Feb; 23(2):153-60. PubMed ID: 3081998
[TBL] [Abstract][Full Text] [Related]
13. Clinical importance of circulating immune complexes in human acute lymphoblastic leukemia.
Croce MV; Fejes M; Riera N; Minoldo DA; Segal-Eiras A
Cancer Immunol Immunother; 1985; 20(1):91-5. PubMed ID: 3877563
[TBL] [Abstract][Full Text] [Related]
14. Circulating immune complexes and rheumatoid arthritis.
Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of interaction between complement-fixing antibody/dsDNA immune complexes and erythrocytes. In vitro studies and potential general applications to clinical immune complex testing.
Taylor RP; Horgan C; Hooper M; Burge J
J Clin Invest; 1985 Jan; 75(1):102-11. PubMed ID: 3917462
[TBL] [Abstract][Full Text] [Related]
16. Specific proteins precipitated by polyethylene glycol during assays for circulating C1q precipitable immune complexes.
Hyun J
Am J Clin Pathol; 1983 Nov; 80(5):777-8. PubMed ID: 6605678
[No Abstract] [Full Text] [Related]
17. [Circulating immune complexes: optimization and characteristics of the C1q(I125) fixation test].
Caillot G; Lamelin JP; Hartmann DJ; Ville G
Pathol Biol (Paris); 1984 Nov; 32(9):931-7. PubMed ID: 6334270
[TBL] [Abstract][Full Text] [Related]
18. [Circulating immune complexes in breast cancer].
Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of different methods for detecting circulating immune complexes. Studies in patients with lung cancer.
Füst G; Fekete B; Angyal I; Jakab A; Pál A; Merétey K; Falus A; Török K; Szegedi G; Kávai M; Puskás E; Csécsi-Nagy M; Szabó T; Lenkey A; Misz M
J Immunol Methods; 1981; 46(3):259-76. PubMed ID: 6975788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]